Literature DB >> 22632395

Mucoadhesive polymers for oral transmucosal drug delivery: a review.

José Bagan1, Carlo Paderni, Nicoletta Termine, Giuseppina Campisi, Lucio Lo Russo, Domenico Compilato, Olga Di Fede.   

Abstract

The oral mucosa offers an interesting site for the application of dosage forms that release drugs within/throughout the oral mucosa, by assuring a high drug bioavailability for topic and systemic effects. However, the relative permeability of the oral mucosa and the washing effect related to the oral fluids and mechanical stresses must be considered in the formulation of oral dosage forms. Since a sustained drug release can be guaranteed only if dosage forms remain in contact with the oral site of absorption/application for a prolonged time, the development of mucoadhesive dosage forms is mandatory. The mucoadhesion is a complex phenomenon and the mucoadhesive bond consists of two different parts, the mucoadhesive polymers and the mucous substrate. In addition to factors related to the oral mucosa and oral environment features, the physical-chemical characteristics of mucoadhesive polymers must be also considered as factors influencing the mucoadhesive bonds. While it is not possible to modify the mucosal features or it is possible to modify or inhibit only in part certain mucosal processes, the knowledge of polymer properties influencing mucoadhesive bonds allows to modify or to control these properties in developing increasingly effective mucoadhesive systems. The aims of this review are to discuss the several mechanisms and factors behind the phenomenon of mucoadhesion with particular reference to the features of the oral environment, oral mucosa, and polymeric compounds influencing mucoadhesion process. Finally, a brief mention to the main mucoadhesive dosage forms designed for oral transmucosal drug delivery is made.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22632395     DOI: 10.2174/138161212803307545

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

1.  Mucoadhesive bilayered buccal platform for antifungal drug delivery into the oral cavity.

Authors:  Burcum Uzunoğlu; Clive G Wilson; Meral Sağıroğlu; Selin Yüksel; Sevda Şenel
Journal:  Drug Deliv Transl Res       Date:  2021-02       Impact factor: 4.617

2.  Development of Mucoadhesive Buccal Film for Rizatriptan: In Vitro and In Vivo Evaluation.

Authors:  Anroop B Nair; Jigar Shah; Shery Jacob; Bandar E Al-Dhubiab; Vimal Patel; Nagaraja Sreeharsha; Pottathil Shinu
Journal:  Pharmaceutics       Date:  2021-05-15       Impact factor: 6.321

3.  Viper and cobra venom neutralization by alginate coated multicomponent polyvalent antivenom administered by the oral route.

Authors:  Sourav Bhattacharya; Mousumi Chakraborty; Piyasi Mukhopadhyay; P P Kundu; Roshnara Mishra
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.